Home > Cashflow Statement > NATCO PHARMA
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax₹1,674 Cr₹862 Cr₹202 Cr₹580 Cr₹569 Cr
Adjustment ₹134 Cr₹102 Cr₹124 Cr₹62 Cr₹54 Cr
Changes In working Capital ₹-309 Cr₹63 Cr₹-231 Cr₹-213 Cr₹-98 Cr
Cash Flow after changes in Working Capital ₹1,498 Cr₹1,027 Cr₹95 Cr₹429 Cr₹525 Cr
Cash Flow from Operating Activities ₹1,212 Cr₹849 Cr₹47 Cr₹299 Cr₹417 Cr
Cash Flow from Investing Activities ₹-1,033 Cr₹-477 Cr₹-5.30 Cr₹-103 Cr₹-167 Cr
Cash Flow from Financing Activities ₹-247 Cr₹-363 Cr₹35 Cr₹-186 Cr₹-251 Cr
Net Cash Inflow / Outflow ₹-68 Cr₹9.00 Cr₹76 Cr₹9.80 Cr₹-0.50 Cr
Opening Cash & Cash Equivalents ₹132 Cr₹111 Cr₹26 Cr₹20 Cr₹28 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹6.50 Cr₹12 Cr₹9.30 Cr₹-3.80 Cr₹-8.00 Cr
Closing Cash & Cash Equivalent ₹70 Cr₹132 Cr₹111 Cr₹26 Cr₹20 Cr

Compare Cashflow Statement of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,786.8 Cr 2.6% 5.7% -15.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,068.0 Cr 1.4% 0.1% 13.9% Stock Analytics
DIVIS LABORATORIES ₹177,105.0 Cr 0.8% 12.3% 47.2% Stock Analytics
CIPLA ₹122,016.0 Cr 2.6% -0.1% 0.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,651.0 Cr 7.8% 12.9% 13.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹108,942.0 Cr 2.7% -0.6% 14.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

2.6%

5.7%

-15.2%

SENSEX

2.1%

3.7%

14.3%


You may also like the below Video Courses